L-Aspartic acid,N-[4-[[(2,4-diamino-5-methyl-6-quinazolinyl)methyl]amino]benzoyl]-

Suppliers

Names

[ CAS No. ]:
18921-70-5

[ Name ]:
L-Aspartic acid,N-[4-[[(2,4-diamino-5-methyl-6-quinazolinyl)methyl]amino]benzoyl]-

[Synonym ]:
Methasquin
N-{4-[(2,4-diamino-5-methyl-quinazolin-6-ylmethyl)-amino]-benzoyl}-aspartic acid
Aspartic acid,N-(p-(((2,4-diamino-5-methyl-6-quinazolinyl)methyl)amino)benzoyl)-,L
N-(p-(((2,4-Diamino-5-methyl-6-quinazolinyl)methyl)amino)benzoyl)-L-aspartic acid

Chemical & Physical Properties

[ Molecular Formula ]:
C21H22N6O5

[ Molecular Weight ]:
438.43700

[ Exact Mass ]:
438.16500

[ PSA ]:
193.55000

[ LogP ]:
2.99870

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
CI9320000
CHEMICAL NAME :
Aspartic acid, N-(p-(((2,4-diamino-5-methyl-6-quinazolinyl)methyl)am ino)benzoyl)-, L-
CAS REGISTRY NUMBER :
18921-70-5
LAST UPDATED :
199612
DATA ITEMS CITED :
3
MOLECULAR FORMULA :
C21-H22-N6-O5
MOLECULAR WEIGHT :
438.49

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
50110 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
158 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value

MUTATION DATA

TYPE OF TEST :
Mutation test systems - not otherwise specified
TEST SYSTEM :
Human Lymphocyte
DOSE/DURATION :
17 nmol/L
REFERENCE :
BCPCA6 Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- Volume(issue)/page/year: 25,1947,1976

Related Compounds

  • N-{[2-(dimethylamino)pyridin-4-yl]methyl}-9-[(oxolan-2-yl)methyl]-9H-purin-6-amine
  • 3-Bromo-4-(4-{pyrazolo[1,5-a]pyrimidin-5-yloxy}piperidin-1-yl)pyridine
  • 4-{3-bromo-6H,7H,8H,9H-pyrido[2,3-b]1,6-naphthyridine-7-carbonyl}-1-methyl-1H-imidazole
  • 4-({4-[6-(2-methyl-1H-imidazol-1-yl)pyridin-2-yl]piperazin-1-yl}methyl)benzonitrile
  • 1-[6-(1H-imidazol-1-yl)pyridin-2-yl]-4-[6-(trifluoromethyl)pyridin-3-yl]piperazine
  • 2-(1-methyl-1H-pyrazol-4-yl)-6-{4-[6-(trifluoromethyl)pyridin-3-yl]piperazin-1-yl}pyrazine
  • 1-{2-Cyclopropylpyrazolo[1,5-a]pyrazin-4-yl}-4-(2,4-difluorophenyl)piperazine
  • 1-{3-Cyclopropyl-[1,2,4]triazolo[4,3-b]pyridazin-6-yl}-4-[4-(trifluoromethyl)phenyl]piperazine
  • N-[5-(4-{pyrazolo[1,5-a]pyrazin-4-yl}piperazin-1-yl)pyridin-2-yl]cyclopropanecarboxamide
  • 6-Cyclopropyl-2-(4-{pyrazolo[1,5-a]pyrimidin-5-yl}piperazin-1-yl)-3,4-dihydropyrimidin-4-one
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.